Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Oneness Biotech Co's Enterprise Value is NT$17,990.5 Mil.
Oneness Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-486.7 Mil. Therefore, Oneness Biotech Co's EV-to-FCF for today is -36.96.
The historical rank and industry rank for Oneness Biotech Co's EV-to-FCF or its related term are showing as below:
ROCO:4743'
s EV-to-FCF Range Over the Past 10 Years
Min: -12055.57 Med: -61.09 Max: 18329.68
Current: -42.48
During the past 13 years, the highest EV-to-FCF of Oneness Biotech Co was 18329.68. The lowest was -12055.57. And the median was -61.09.
ROCO:4743's EV-to-FCF is ranked worse than 100% of 335
companies
in the Biotechnology industry
Industry Median: 15.51
vs ROCO:4743: -42.48
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Oneness Biotech Co (ROCO:4743) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Oneness Biotech Co's PE Ratio (TTM) for today is calculated as:
Oneness Biotech Co's share price for today is NT$48.60.
Oneness Biotech Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-2.180.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Oneness Biotech Co EV-to-FCF Related Terms
Oneness Biotech Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Oneness Biotech Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4743 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Oneness Biotech Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oneness Biotech Co EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Oneness Biotech Co's EV-to-FCF falls into.
Oneness Biotech Co's current Enterprise Value is NT$17,990.5 Mil.
Oneness Biotech Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-486.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oneness Biotech Co (ROCO:4743) has a EV-to-FCF of -36.96 as of Jul. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Oneness Biotech Co and its competitors. According to the industry distribution chart, Oneness Biotech Co ranks #999999 out of 335 companies in the Biotechnology industry.
Is Oneness Biotech Co's EV-to-FCF too high?
Oneness Biotech Co's current EV-to-FCF is -36.96. Based on the distribution chart, Oneness Biotech Co ranks #999999 out of 335 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Oneness Biotech Co has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Oneness Biotech Co's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oneness Biotech Co ranks #999999 out of 335 companies for EV-to-FCF. This places Oneness Biotech Co in the lower half of its industry. The industry median EV-to-FCF is 15.51. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 15.51, based on 335 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Oneness Biotech Co and its competitors. For the Biotechnology industry, the median EV-to-FCF is 15.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oneness Biotech Co's current EV-to-FCF is -36.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oneness Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Oneness Biotech Co (ROCO:4743) is currently considered Possible Value Trap. The stock's GF Value™ is NT$81.63, compared to a current price of NT$48.60 — trading 40.5% below its estimated fair value. The current EV-to-FCF is -36.96. Oneness Biotech Co's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Oneness Biotech Co (ROCO:4743), the current EV-to-FCF is -36.96 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oneness Biotech Co (ROCO:4743) Overvalued in 2026?
Based on GuruFocus' analysis, Oneness Biotech Co stock appears to be undervalued.
The current stock price of NT$48.60 is trading 40.5% below its estimated GF Value™ of NT$81.63.
GuruFocus considers Oneness Biotech Co to be Possible Value Trap.
Key valuation signals for ROCO:4743:
EV-to-FCF: -36.96
GF Value™: NT$81.63 vs. price of NT$48.60 (40.5% below fair value)
No single metric tells the full story. See the ROCO:4743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The Group's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and Bonvadis, a wound care medical device. It also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, SNS851, and others. The Group operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation and organic food segment.
59GF Score
Get the complete analysis for ROCO:4743
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4743 has been successfully added to your 
